Morgan Stanley calls this health insurance event the best, seeing more than 20% growth

Morgan Stanley thinks it’s time to buy Elevance Health stock. The bank listed the stock as a top performer in a note on Tuesday and reiterated its overweight rating. Morgan Stanley’s $585 price target implies a roughly 24% upside from Monday’s close of $471.16. Morgan Stanley analyst Michael Ha said the health insurer can shine […]